A low MDR2 expression, together with a high COX2 expression were associated with lower pTNM and clinical stages, and may also be considered as possible favourable prognostic markers, specific for early stages of MTC progression. This evidence concerns the gene ABCB4 and medullary thyroid gland carcinoma.